March 12, 2018
Company receives second patent related to tissue contact control March 12, 2018 05:30 AM Mountain Daylight Time SALT LAKE CITY–(BUSINESS WIRE)–XableCath, Inc., innovators of products designed to aid in the treatment of peripheral artery disease (PAD), announced that it has Read more…
